SMC accepts Stivarga (regorafenib) for use in Scotland for the treatment of adult patients with gastrointestinal stromal tumours (GIST)

The Scottish Medicines Consortium (SMC) has announced that Stivarga® (regorafenib) has been accepted for use within NHS Scotland for the treatment of adult patients with unresectable or...